Impact of Healthcare System: Taiwan’s healthcare system may pose challenges to Pfizer’s business model, affecting the company’s revenues and resource allocation.
External Competition Pressure: The presence of numerous competitors in the market may affect Pfizer’s market share and pricing strategies.
Staffing Constraints: Due to changes in policies and market conditions, Pfizer’s staffing may be restricted, hindering the ability to quickly expand or adjust team configurations to meet demand.
Resource Investment Not Always Effective: The company may face uneven resource allocation, where investments in certain critical areas may not achieve the desired outcomes.